News

NIH expands cancer research program to include breast density


 

References

Officials at the National Institutes of Health are taking a closer look at the role that breast density plays in the development of breast cancer.

As part of the agency’s Breast Cancer and the Environment Research Program (BCERP), grant-funded researchers are being tasked with expanding the study of risk factors that precede breast cancer such as breast density. They will also include more racially and ethnically diverse populations in their studies.

Dr. Cecil Fox/National Cancer Institute

The research will be conducted at six centers: Brigham and Women’s Hospital, Boston; City of Hope/Beckman Research Institute, Duarte, Calif.; Columbia University, New York; Georgetown Lombardi Comprehensive Cancer Center, Washington; Michigan State University, Lansing; University of Massachusetts, Amherst. The research will be coordinated by another center at the University of Wisconsin, Madison.

Breast density is a new area of focus for the NIH. The researchers will consider dense breast tissue as a possible intermediate risk factor for breast cancer with the goal of identifying links between environmental exposures and high breast density, which could provide future prevention strategies.

“These priorities reflect our continued commitment to breast cancer prevention,” Caroline H. Dilworth, Ph.D., BCERP program lead at the National Institute of Environmental Health Sciences, said in a statement. “Our goal is to build on the high-quality science we’ve been funding for more than a decade, while also being responsive to the expert recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee] report.”

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

ASCO: Many women with triple-negative breast cancer aren’t screened for BRCA
MDedge Hematology and Oncology
ASCO: Neoadjuvant chemo does not increase breast cancer surgery complications
MDedge Hematology and Oncology
ASCO: Potentially targetable biomarkers identified in geriatric breast cancer tumors
MDedge Hematology and Oncology
Computer-aided detection fails to improve mammographic accuracy
MDedge Hematology and Oncology
Two heads plus four hands equal safe, shorter bilateral mastectomies
MDedge Hematology and Oncology
Dose-dense breast chemotherapy is also cost dense
MDedge Hematology and Oncology
Positive lumpectomy margin risk rises with breast density
MDedge Hematology and Oncology
Nipple-sparing mastectomy feasible in N+ early breast cancer
MDedge Hematology and Oncology
VIDEO: When to use MRI in breast cancer
MDedge Hematology and Oncology
Race, age, BMI had no impact on pCR rates
MDedge Hematology and Oncology